bymuratdeniz/iStock via Getty Images Inovio Pharmaceutical (INO) won an $80.4M judgment in a lawsuit that accused VGXI and GeneOne Life Sciences of violating a supply agreement. Inovio argued that the two companies declined to abide by technology transfer obligations that would have allowed Source link Like this:Like Loading… Related Post navigation Bridgewater Bancshares Non-GAAP EPS of $0.49 beats by $0.02, revenue of $43.2M beats by $1.4M (BWB:NASDAQ)
